Pathophysiology of hypertension in pre-eclampsia: A lesson in integrative physiology

Acta Physiologica

Volumn 208, Issue 3, 2013, Pages 224-233

  Palei, A C ^a,b   Spradley, F T ^a,b   Warrington, J P ^a,b   George, E M ^a,b   Granger, J P ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hypertension; Pre eclampsia; Pregnancy

Indexed keywords

ENDOTHELIN; HEME OXYGENASE; MESSENGER RNA; NITRIC OXIDE;

ANGIOGENESIS; BLOOD VESSEL INJURY; CYTOTROPHOBLAST; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION; HUMAN; HYPOXIA; INFLAMMATION; KIDNEY CORTEX; KIDNEY DISEASE; MATERNAL HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84879413101     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12106     Document Type: Review

References (71)

1. Abdalvand, A., Morton, J.S., Bourque, S.L., Quon, A.L. & Davidge, S.T. 2013. Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension 61, 488-493.
2. Ahmed, A. & Cudmore, M.J. 2009. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem Soc Trans 37, 1237-1242.
3. Ahmed, A., Rahman, M., Zhang, X., Acevedo, C.H., Nijjar, S., Rushton, I., Bussolati, B. & St John, J. 2000. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6, 391-409.
4. Alexander, B.T., Kassab, S.E., Miller, M.T., Abram, S.R., Reckelhoff, J.F., Bennett, W.A. & Granger, J.P. 2001. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37, 1191-1195.
5. Alexander, B.T., Llinas, M.T., Kruckeberg, W.C. & Granger, J.P. 2004. l-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 43, 832-836.
6. Benigni, A., Orisio, S., Gaspari, F., Frusca, T., Amuso, G. & Remuzzi, G. 1992. Evidence against a pathogenetic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 99, 798-802.
7. Berends, A.L., Bertoli-Avella, A.M., de Groot, C.J., van Duijn, C.M., Oostra, B.A. & Steegers, E.A. 2007. STOX1 gene in pre-eclampsia and intrauterine growth restriction. BJOG 114, 1163-1167.
8. Brosens, I.A., Robertson, W.B. & Dixon, H.G. 1972. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1, 177-191.
9. Burton, G.J. & Yung, H.W. 2011. Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia. Pregnancy Hypertens 1, 72-78.
10. Buzza, M.S., Hosking, P. & Bird, P.I. 2006. The granzyme B inhibitor, PI-9, is differentially expressed during placental development and up-regulated in hydatidiform moles. Placenta 27, 62-69.
11. Cao, J., Inoue, K., Li, X., Drummond, G. & Abraham, N.G. 2009. Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol 41, 1025-1033.
12. Colucci, F., Boulenouar, S., Kieckbusch, J. & Moffett, A. 2011. How does variability of immune system genes affect placentation? Placenta 32, 539-545.
13. Conrad, K.P., Kerchner, L.J. & Mosher, M.D. 1999. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 277, F48-F57.
14. Cudmore, M., Ahmad, S., Al-Ani, B., Fujisawa, T., Coxall, H., Chudasama, K., Devey, L.R., Wigmore, S.J., Abbas, A., Hewett, P.W. & Ahmed, A. 2007. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115, 1789-1797.
15. Damsky, C.H. & Fisher, S.J. 1998. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol 10, 660-666.
16. Davidge, S.T., Stranko, C.P. & Roberts, J.M. 1996. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174, 1008-1013.
17. Deng, A., Engels, K. & Baylis, C. 1996. Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat. Kidney Int 50, 1132-1138.
18. van Dijk, M., Mulders, J., Poutsma, A., Konst, A.A., Lachmeijer, A.M., Dekker, G.A., Blankenstein, M.A. & Oudejans, C.B. 2005. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 37, 514-519.
19. Doridot, L., Passet, B., Mehats, C., Rigourd, V., Barbaux, S., Ducat, A., Mondon, F., Vilotte, M., Castille, J., Breuiller-Fouche, M. et al. 2013. Preeclampsia-Like Symptoms Induced in Mice by Fetoplacental Expression of STOX1 Are Reversed by Aspirin Treatment. Hypertension 61, 662-668.
20. Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.P., Kikkawa, Y., Miner, J.H. & Quaggin, S.E. 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111, 707-716.
21. Fukui, A., Yokota, M., Funamizu, A., Nakamua, R., Fukuhara, R., Yamada, K., Kimura, H., Fukuyama, A., Kamoi, M., Tanaka, K. & Mizunuma, H. 2012. Changes of NK cells in preeclampsia. Am J Reprod Immunol 67, 278-286.
22. George, E.M. & Granger, J.P. 2011. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 24, 964-969.
23. George, E.M., Cockrell, K., Aranay, M., Csongradi, E., Stec, D.E. & Granger, J.P. 2011. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57, 941-948.
24. George, E.M., Colson, D., Dixon, J., Palei, A.C. & Granger, J.P. 2012. Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens 2012, 486053.
25. Germain, S.J., Sacks, G.P., Sooranna, S.R., Sargent, I.L. & Redman, C.W. 2007. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178, 5949-5956.
26. Gifford, R.W., August, P.A., Cunningham, G., Green, L.A., Lindheimer, M.D., McNellis, D. & AL, E. 2000. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183, S1-S22.
27. Gilbert, J.S., Ryan, M.J., LaMarca, B.B., Sedeek, M., Murphy, S.R. & Granger, J.P. 2008. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294, H541-H550.
28. Herse, F., Staff, A.C., Hering, L., Muller, D.N., Luft, F.C. & Dechend, R. 2008. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med (Berl) 86, 697-703.
29. Hung, T.H. & Burton, G.J. 2006. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45, 189-200.
30. Hunkapiller, N.M., Gasperowicz, M., Kapidzic, M., Plaks, V., Maltepe, E., Kitajewski, J., Cross, J.C. & Fisher, S.J. 2011. A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development 138, 2987-2998.
31. Iglesias-Platas, I., Monk, D., Jebbink, J., Buimer, M., Boer, K., van der Post, J., Hills, F., Apostolidou, S., Ris-Stalpers, C., Stanier, P. & Moore, G.E. 2007. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat Genet, 39, 279-280; author reply 280-1.
32. Irani, R.A. & Xia, Y. 2011. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol 31, 47-58.
33. Krauss, T., Kuhn, W., Lakoma, C. & Augustin, H.G. 1997. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 177, 443-449.
34. LaMarca, B.B., Cockrell, K., Sullivan, E., Bennett, W. & Granger, J.P. 2005. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46, 82-86.
35. LaMarca, B., Wallukat, G., Llinas, M., Herse, F., Dechend, R. & Granger, J.P. 2008a. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 52, 1168-1172.
36. LaMarca, B.D., Gilbert, J. & Granger, J.P. 2008b. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51, 982-988.
37. LaMarca, B., Parrish, M., Ray, L.F., Murphy, S.R., Roberts, L., Glover, P., Wallukat, G., Wenzel, K., Cockrell, K., Martin, J.N. Jr & Ryan, M.J. & Dechend, R. 2009. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54, 905-909.
38. LaMarca, B., Parrish, M.R. & Wallace, K. 2012. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia. Gend Med 9, 139-146.
39. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., Schisterman, E.F., Thadhani, R., Sachs, B.P., Epstein, F.H., Sibai, B.M., Sukhatme, V.P. & Karumanchi, S.A. 2004. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350, 672-683.
40. Mastrogiannis, D.S., O'brien, W.F., Krammer, J. & Benoit, R. 1991. Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 165, 1711-1716.
41. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E., Epstein, F.H., Sukhatme, V.P. & Karumanchi, S.A. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111, 649-658.
42. Murphy, S.R., LaMarca, B.B., Cockrell, K. & Granger, J.P. 2010. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55, 394-398.
43. Mutter, W.P. & Karumanchi, S.A. 2008. Molecular mechanisms of preeclampsia. Microvasc Res 75, 1-8.
44. Nelissen, E.C., van Montfoort, A.P., Dumoulin, J.C. & Evers, J.L. 2011. Epigenetics and the placenta. Hum Reprod Update 17, 397-417.
45. Palei, A.C., Granger, J.P. & Tanus-Santos, J.E. 2013. Matrix metalloproteinases as drug targets in preeclampsia. Curr Drug Targets 14, 325-334.
46. Parrish, M.R., Murphy, S.R., Rutland, S., Wallace, K., Wenzel, K., Wallukat, G., Keiser, S., Ray, L.F., Dechend, R., Martin, J.N., Granger, J.P. & LaMarca, B. 2010. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens 23, 911-916.
47. Parrish, M.R., Wallace, K., Tam Tam, K.B., Herse, F., Weimer, A., Wenzel, K., Wallukat, G., Ray, L.F., Arany, M., Cockrell, K., Martin, J.N., Dechend, R. & LaMarca, B. 2011. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens, 24, 835-840.
48. Pijnenborg, R., Vercruysse, L. & Hanssens, M. 2008. Fetal-maternal conflict, trophoblast invasion, preeclampsia, and the red queen. Hypertens Pregnancy 27, 183-196.
49. Prins, J.R., Boelens, H.M., Heimweg, J., van der Heide, S., Dubois, A.E., van Oosterhout, A.J. & Erwich, J.J. 2009. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 28, 300-311.
50. Redman, C.W. & Sargent, I.L. 2010. Immunology of pre-eclampsia. Am J Reprod Immunol 63, 534-543.
51. Redman, C.W., Tannetta, D.S., Dragovic, R.A., Gardiner, C., Southcombe, J.H., Collett, G.P. & Sargent, I.L. 2012. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33(Suppl), S48-S54.
52. Rigourd, V., Chauvet, C., Chelbi, S.T., Rebourcet, R., Mondon, F., Letourneur, F., Mignot, T.M., Barbaux, S. & Vaiman, D. 2008. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS ONE 3, e3905.
53. Roberts, J.M. & Gammill, H.S. 2005. Preeclampsia: recent insights. Hypertension 46, 1243-1249.
54. Roberts, J.M., Taylor, R.N. & Goldfien, A. 1991. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4, 700-708.
55. Roberts, J.M., Bodnar, L.M., Patrick, T.E. & Powers, R.W. 2011. The Role of Obesity in Preeclampsia. Pregnancy Hypertens 1, 6-16.
56. Roggensack, A.M., Zhang, Y. & Davidge, S.T. 1999. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33, 83-89.
57. Sedeek, M., Gilbert, J.S., LaMarca, B.B., Sholook, M., Chandler, D.L., Wang, Y. & Granger, J.P. 2008. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 21, 1152-1156.
58. Taylor, R.N., Varma, M., Teng, N.N. & Roberts, J.M. 1990. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71, 1675-1677.
59. Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O.A., Kreyssig, C. et al. 2011. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940-950.
60. Thaete, L.G., Khan, S., Synowiec, S., Dayton, B.D., Bauch, J. & Neerhof, M.G. 2012. Endothelin receptor antagonist has limited access to the fetal compartment during chronic maternal administration late in pregnancy. Life Sci 91, 583-586.
61. Todkar, A., Di Chiara, M., Loffing-Cueni, D., Bettoni, C., Mohaupt, M., Loffing, J. & Wagner, C.A. 2012. Aldosterone deficiency adversely affects pregnancy outcome in mice. Pflugers Arch 464, 331-343.
62. Wallace, K., Richards, S., Dhillon, P., Weimer, A., Edholm, E.S., Bengten, E., Wilson, M., Martin, J.N. Jr & LaMarca, B. 2011. CD4 + T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57, 949-955.
63. Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jupner, A., Baur, E., Nissen, E., Vetter, K., Neichel, D., Dudenhausen, J.W., Haller, H. & Luft, F.C. 1999. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103, 945-952.
64. Walsh, S.W. 1998. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16, 93-104.
65. Walther, T., Jank, A., Heringer-Walther, S., Horn, L.C. & Stepan, H. 2008. Angiotensin II type 1 receptor has impact on murine placentation. Placenta 29, 905-909.
66. Wang, R., Shamloul, R., Wang, X., Meng, Q. & Wu, L. 2006. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48, 685-692.
67. Wang, A., Rana, S. & Karumanchi, S.A. 2009. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24, 147-158.
68. Zhao, H., Wong, R.J., Kalish, F.S., Nayak, N.R. & Stevenson, D.K. 2009. Effect of heme oxygenase-1 deficiency on placental development. Placenta 30, 861-868.
69. Zhou, Y., Fisher, S.J., Janatpour, M., Genbacev, O., Dejana, E., Wheelock, M. & Damsky, C.H. 1997. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99, 2139-2151.
70. Zhou, C.C., Zhang, Y., Irani, R.A., Zhang, H., Mi, T., Popek, E.J., Hicks, M.J., Ramin, S.M., Kellems, R.E. & Xia, Y. 2008. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14, 855-862.
71. Zhu, X., Wu, S., Dahut, W.L. & Parikh, C.R. 2007. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis 49, 186-193.